Abacavir, dolutegravir, and lamivudine and Liver impairment
Result of checking the interaction of drug Abacavir, dolutegravir, and lamivudine and disease Liver impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The effect of severe hepatic impairment (Child - Pugh C) on the pharmacokinetics of dolutegravir has not been studied, therefore dolutegravir is not recommended for use on these patients. No dosage adjustment is needed for patients with mild or moderate hepatic impairment.
Generic Name: abacavir / dolutegravir / lamivudine
Brand Name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Abacavir, dolutegravir, and lamivudine - zaburzenia czynności wątroby 
Abacavir, dolutegravir, and lamivudine - insuficiência hepática 
Abacavir, dolutegravir, and lamivudine - gangguan hati 
Abacavir, dolutegravir, and lamivudine - kerusakan hati 
Abacavir, dolutegravir, and lamivudine - insufficienza epatica 
Abacavir, dolutegravir, and lamivudine - insuffisance hépatique 
Abacavir, dolutegravir, and lamivudine - Leberfunktionsstörung 
Abacavir, dolutegravir, and lamivudine - insuficiencia hepática 
Abacavir, dolutegravir, and lamivudine - нарушение функции печени 
Abacavir, dolutegravir, and lamivudine - karaciğer yetmezliği 
Abacavir, dolutegravir, and lamivudine - ضعف الكبد 
Abacavir, dolutegravir, and lamivudine - 肝功能不全